Sera Prognostics SERA
NASDAQ SERA
$2.07 +0.08 (+4.02%)
As of: Aug 20, 2026 · 3:59 PM EDT

Sera Prognostics (SERA) Long-Term Debt Repayments (2020 - 2021)

Sera Prognostics' (SERA) quarterly Long-Term Debt Repayments came in at $4.5 million in Q1 2021, up 349.4% on a QoQ basis from $1.0 million in Q4 2020.

Sera Prognostics (SERA) Long-Term Debt Repayments (2020 - 2021) Analysis & Trends

Sera Prognostics (SERA) has 2 years of Long-Term Debt Repayments data on file, last reported at $4.5 million in Q1 2021.

  • Quarterly Long-Term Debt Repayments changed N/A year-over-year to $4.5 million in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $4.5 million (changed N/A YoY) and the FY2021 annual result came in at $4.5 million, up 68.5% from the prior year.
  • Long-Term Debt Repayments advanced to $4.5 million in Q1 2021, from $1.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $4.5 million in Q1 2021 to a low of $1.0 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 1.41 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -927.56 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Sera Prognostics 103.48 Mn 103.48 Mn -20,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2021 4.49 Mn
Mar 31, 2021 4.49 Mn
Dec 31, 2020 1.00 Mn
Dec 31, 2020 1.00 Mn
Sep 30, 2020 1.00 Mn
Sep 30, 2020 1.00 Mn